
Viewpoint: A shot in the arm for generics producers
Domino inksThere is nowhere to hide from the Falsified Medicines Directive. It impacts generics producers in the same way as any other drug manufacturer or re-packager selling into Europe. With just under 48 months to go before the deadline, which is likely to be mid-2018, the clock is ticking for all producers to get their house in order.
The subject was hot on the agenda at the European Generics Association (EGA) meeting in Madrid earlier this month. As generics manufacturers often supply products with much lower margins than patented drug producers, their budgets are restricted when it comes to new investment – which is why many of them have been holding out until the last minute to find the ‘best-fit’ solution for their businesses.
Related Posts
Uttar Pradesh: Gold smugglers held after hot chase by Directorate of Revenue Intelligence
LUCKNOW: Two SUVs ferrying smugglers carrying 77 gold bars weighing about nine kg...
Australian Border Force officers arrest two Chinese nationals over seizure of 1.3 million allegedly illegally imported cigarettes
Authorities have seized more than 1.3 million allegedly illegally imported...
Fake products in high demand
The Indonesian Anti-Counterfeiting Society (MIAP), the Food and Drug Monitoring...
Honeywell Safety Products appoints new global president
Honeywell has appointed Sach Sankpal as Global President for its Safety Products...